Relationship between adiponectin and left atrium size in uncomplicated obese patients: Adiponectin, a link between fat and heart

Obesity Surgery

Volumn 19, Issue 9, 2009, Pages 1324-1332

  Ybarra, Juan ^a,b   Resmini, Eugenia ^b   Planas, Francesc ^a   Navarro López, Francesc ^a   Webb, Susan ^b   Pou, Jose Maria ^b   Santos, Alicia ^b   Ballesta López, Carlos ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adiponectin; Left atrium size; Morbid obesity

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT ATRIUM; HEART OUTPUT; HEART VENTRICLE VOLUME; HEART VOLUME; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART ATRIA; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; STROKE VOLUME; YOUNG ADULT;

EID: 69249218942     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-9924-5     Document Type: Article

References (58)

1. AH Mokdad BA Bowman ES Ford, et al. 2001 The continuing epidemics of obesity and diabetes in the United States JAMA 286 1195 1200
2. S Yusuf S Hawken S Ounpuu, et al. 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952
3. National Institutes of Health Consensus Development Conference 1985 Health implications of obesity Ann Intern Med 103 977
4. HB Hubert M Feinleib PM McNamara, et al. 1983 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 968 977
5. S Kenchaiah JC Evans D Levy, et al. 2002 Obesity and the risk of heart failure N Engl J Med 347 305 313
6. TJ Wang H Parise D Levy, et al. 2004 Obesity and the risk of new-onset atrium fibrillation JAMA 292 2471 2477
7. NF Murphy K MacIntyre S Stewart, et al. 2006 Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15.000 middle-aged men and women (the Renfrew-Paisley study) Eur Heart J 27 96 106
8. Y Miyasaka ME Barnes BJ Gersh, et al. 2006 Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119 125
9. DA Pascual F Soria T Vicente, et al. 2003 Effects of isolated obesity on systolic and diastolic left ventricle function Heart 89 1152 1156
10. R Scaglione MA Dichiara A Indovina, et al. 1992 Left ventricle diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity Eur Heart J 13 738 742
11. A Bayes-Genis R Vazquez T Puig, et al. 2007 Left atrium enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure Eur J Heart Fail 9 802 807
12. SW Zarich GJ Kowalchuk MP McGuire, et al. 1991 Left ventricle filling abnormalities in asymptomatic morbid obesity Am J Cardiol 68 377 381
13. Chakko S. Obesity and ventricle function in man: diastolic dysfunction. In: Alpeert MAAJ, editor. Obesity. New York: Armonk; 1998. p. 57-76.
14. MR Zile CF Baicu WH Gaasch, et al. 2004 Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle N Engl J Med 350 1953 1959
15. L Mont D Tamborero R Elosua, et al. 2008 Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals Europace 10 15 20
16. TS Tsang ME Barnes Y Miyasaka, et al. 2008 Obesity as a risk factor for the progression of paroxysmal to permanent atrium fibrillation: a longitudinal cohort study of 21 years Eur Heart J 29 2227 2233
17. CJ Lyon RE Law WA Hsueh 2003 Minireview: adiposity, inflammation, and atherogenesis Endocrinology 144 2195 2200
18. PE Scherer S Williams M Fogliano, et al. 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 26746 26749
19. M Yoda-Murakami M Taniguchi K Takahashi, et al. 2001 Change in expression of GBP28/adiponectin in carbon tetrachloride administrated mouse liver Biochem Biophys Res Commun 285 372 377
20. AM Delaigle JC Jonas IB Bauche, et al. 2004 Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies Endocrinology 145 5589 5597
21. R Piñeiro MJ Iglesias R Gallego, et al. 2005 Adiponectin is synthesized and secreted by human and murine cardiomyocytes FEBS Lett 579 5163 5169
22. O Gualillo JR González-Juanatey F Lago 2007 The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives Trends Cardiovasc Med 17 275 283
23. TS Hermann W Li H Domínguez, et al. 2006 Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes J Clin Endocrinol Metab 91 1001 1008
24. PS Bora S Kaliappan VV Lyzogubov, et al. 2007 Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin FEBS Lett 581 1977 1982
25. Y Izumiya K Sato K Papanicolaou, et al. 2007 Adiponectin protects against the development of systolic dysfunction following myocardial infarction J Mol Cell Cardiol 42 1065 1074
26. G Ding Q Qin N He, et al. 2007 Adiponectin and its receptors are expressed in adult ventricle cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma J Mol Cell Cardiol 43 73 84
27. M Shimano R Shibata Y Tsuji, et al. 2008 Circulating adiponectin levels in patients with atrial fibrillation Circ J 72 1120 1124
28. G Mancia G de Backer A Dominiczak, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 1105 1187 (Pubitemid 46924065)
29. LE Teichholz TH Kreulen MV Herman, et al. 1976 Problems in echocardiographic volume determinations: echocardiographic-angiographic correlation in the presence of absence of asynergy Am J Cardiol 37 7 11
30. RB Devereux N Reiche 1987 Echocardiographic determination of left ventricular mass in man. Anatomic evaluation of the method Circulation 59 956 960
31. D Levy DD Savage RJ Garrison, et al. 1987 Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study Am J Cardiol 59 956 960 (Pubitemid 17074242)
32. MA Quinones CM Otto M Stoddard, et al. 2002 Recommendations for quantification of Doppler echocardiography. A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 167 184
33. M Alam J Wardell E Anderson, et al. 1999 Characteristics of mitral and tricuspid annular velocities determined by pulsed wave Doppler tissue imaging in healthy subjects J Am Soc Echocardiogr 12 618 628
34. SR Ommen RA Nishimura CP Appleton, et al. 2000 Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study Circulation 102 1788 1794
35. DR Matthews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 412 419
36. MW Steffes MD Gross DH Lee, et al. 2006 Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study Obesity 14 319 326
37. MF Herrera J Oseguera R Gamino, et al. 1998 Cardiac abnormalities associated with morbid obesity World J Surg 22 993 997
38. Y Arita S Kihara N Ouchi, et al. 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 79 83
39. Y Iwashima T Katsuya K Ishikawa, et al. 2004 Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 1318 1323
40. GD Kolovou PM Kostakou KK Anagnostopoulou, et al. 2008 Therapeutic effects of fibrates in postprandial lipemia Am J Cardiovasc Drugs 8 243 255
41. FJ Tinahones M Murri-Pierri L Garrido-Sánchez, et al. 2009 Oxidative stress in severely obese persons is greater in those with insulin resistance Obesity (Silver Spring) 17 240 246
42. J Ybarra J Pou F Planas, et al. 2007 Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study Endocr Pract 13 590 600
43. E Bonora G Targher M Alberich, et al. 2000 Homeostasis model assessment mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies on subjects with various degrees of glucose intolerance and insulin sensitivity Diabetes Care 23 57 63
44. PE Scherer 2006 Adipose tissue: from lipid storage compartment to endocrine organ Diabetes 55 1537 1545
45. JV Silha M Krsek JV Skrha, et al. 2003 Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Eur J Endocrinol 149 331 335 (Pubitemid 37304704)
46. JV Patel A Abraheem O Dotsenko, et al. 2008 Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function J Intern Med 264 593 598
47. E Cavusoglu V Chopra V Battala, et al. 2008 Baseline plasma adiponectin levels as a predictor of left ventricle systolic dysfunction in patients referred for coronary angiography Am J Cardiol 101 1073 1078
48. H Takano JE Obata Y Kodama, et al. 2009 Adiponectin is released from the heart in patients with heart failure Int J Cardiol 132 221 226
49. D Aristizabal J Gallo R Fernández, et al. 2008 The insulin gradient phenomenon: a manifestation of the effects of body weight on blood pressure and insulin resistance J Cardiometab Syndr 3 218 223
50. H Ebinç FA Ebinç ZN Ozkurt, et al. 2008 Impact of adiponectin on left ventricle mass index in non-complicated obese subjects Endocr J 55 523 528
51. DCW Lau B Dhillon H Yan, et al. 2005 Adipokines: molecular links between obesity and atherosclerosis Am J Physiol Heart Circ Physiol 288 2031 2041
52. L Fontana JC Eagon ME Trujillo, et al. 2007 Visceral fat adipokine secretion is associated with systemic inflammation in obese subjects Diabetes 56 1010 1013
53. F Lago C Diéguez J Gómez-Reino, et al. 2007 The emerging role of adipokines as mediators of inflammation and immune responses Cytokine Growth Factor Rev 18 313 325 (Pubitemid 46891288)
54. MA Lazar 2005 How obesity causes diabetes: not a at all tale Science 307 373 375
55. YT Zhou P Grayburn A Karim, et al. 2000 Lipotoxic heart disease in obese rats implication for human obesity Proc Natl Acad Sci U S A 97 1784 1789
56. JG Leichman D Aguilar TM King, et al. 2006 Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity Am J Clin Nutr 84 336 341
57. V Di Bello F Santini A Di Cori, et al. 2006 Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study J Am Soc Echocardiogr 19 1063 1071
58. M Galderisi 2006 Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography J Am Coll Cardiol 48 1548 1551